Crossmark

Clinical Efficacy of a Flavo-Proxylane Topical Regimen Pre- and Post-ultrasound Procedure for Subjects Undergoing Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Therapy

Crossref DOI link: https://doi.org/10.1007/s13555-026-01699-w

Published Online: 2026-03-04

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Moradi, Amir

Kim, Jihee H.

Kim, Jemin M.

Choudhary, Hina N.

Brieva, Patricia M. https://orcid.org/0009-0003-5449-7104
Funding

Funding for this research was provided by:

SkinCeuticals
License Information

Text and Data Mining valid from 2026-03-04

Version of Record valid from 2026-03-04
More Information

Article History

Received: 21 January 2026

Accepted: 13 February 2026

First Online: 4 March 2026

Declarations

:

: Drs. Patricia M Brieva and Hina N Choudhary are employees of SkinCeuticals. Drs. Amir Moradi, Jihee H Kim, and Jemin M Kim declare no competing interests.

: Prior to participation, all subjects provided written informed consent. The study protocol, informed consent, and all patient-facing materials were approved by the Sterling Institutional Review Board (Protocol Number SKIN2024-02, September 24, 2025). This study was performed in accordance with the Declaration of Helsinki of 1964 and all updated versions.

Document is current

Any future updates will be listed below